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Background: Recent evidence regarding temporal trends of asthma burden has not been consistent, with some
countries reporting decreases in prevalence of asthma. In Ontario, the province in Canada with the highest
population, the prevalence of asthma rose at a rate of 0.5% per year between 1996 and 2005. These estimates were
based on population-based health services use data spanning more than a decade and provide a powerful source
to forecast the trends of asthma burden. The objective of this study was to use observed population trends data of
asthma incidence and prevalence to forecast future disease burden.
Methods: The Ontario Asthma Surveillance Information System (OASIS) used health administrative databases to
identify and track all individuals in the province with asthma. Individuals with asthma identified between April 1,
1996 and March 31, 2010 were included. Exponential smoothing models were applied to annual data to project
incidence to the year 2022, prevalence was estimated by applying the cumulative projected incidence to the
projected population.
Results: While asthma incidence is falling, the absolute number of prevalent cases will continue to rise. We
projected that almost 1 in 8 individuals in Ontario will have asthma by the year 2022, suggesting that asthma will
continue to be a major burden on individuals and the health care system.
Conclusions: These projections will help inform health care planners and decision-makers regarding resource
allocation to optimize asthma outcomes.Background
In 2004, the Global Initiative of Asthma estimated that
more than 300 million people worldwide were affected
with asthma [1]. In the 1980s and 1990s, many countries
reported significant increases in asthma prevalence, with
more recent studies suggesting that asthma prevalence
may have reached a plateau or may even be decreasing
[2]. These trends seem to be dependent on a country’s
asthma prevalence, whereby high prevalence countries
reported decreases [2]. Conversely, in North America,
both Canada and the United States reported an increase
in the prevalence of asthma [3,4]. Inconsistencies in
findings may be attributed to differences in study de-
signs and data collected from different sources using* Correspondence: teresa.to@sickkids.ca
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reproduction in any medium, provided the orvarying definitions and time points [5]. An understand-
ing of trends of disease prevalence and estimates of fu-
ture disease burden can inform health policy makers
regarding resource allocation in order to optimize health
outcomes.
In the province of Ontario, which has a population of
13 million (one third of Canada’s population), the preva-
lence of asthma was estimated to be 13.3% in 2005,
representing a rise of 0.5% per year since 1996 [3]. On-
tario has a diverse and multi-cultural population, with
several large urban centres as well as remote rural re-
gions. Previous estimates of asthma in Ontario were based
on a validated asthma definition derived from population-
based health services use data [3]. These data span more
than a decade and provide a powerful population-based
source to forecast the trends of asthma incidence and
prevalence. In this study, we aim to describe trends in
asthma incidence and prevalence to forecast future dis-
ease burden based on the observed trends.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Data sources
Ontario has a universal, single-payer health-care system
that covers all physician and hospital services. Data were
available from three health administrative databases:
1) The Ontario Health Insurance Plan Database contains
information on all fee-for-service billings for physician ser-
vices rendered as well as emergency department visits in
Ontario, including a diagnosis, 2) The Canadian Institute
for Health Information Discharge Abstract Database re-
cords the primary diagnosis and up to 15 secondary diag-
noses for all patients discharged from acute-care hospitals
prior to 2002 and up to 25 secondary diagnoses in 2002
and later years, and 3) The Ontario Registered Persons
Database includes information on gender, birth date,
residence postal code, and, if applicable, date of death.
We linked these databases together on an individual
level using an encrypted unique Ontario health card
number given to all Ontario residents. Such linkage al-
lows for protection of the identities of individuals while
examining their health services use across health admi-
nistrative databases. These databases are housed at the
Institute for Clinical Evaluative Sciences in Ontario.Asthma case definition
The Ontario Asthma Surveillance Information System
(OASIS) used the above mentioned databases to create a
population-based longitudinal surveillance system which
identifies and tracks individuals living with asthma
[3,6,7]. Individuals with asthma were identified as those
who had at least two asthma outpatient claims in two
consecutive years or at least one hospitalization for
asthma. This health administrative data case definition
for asthma has previously been validated and has been
shown to have 89% sensitivity and 72% specificity in
children (under 18 years old) and 83.8% sensitivity and
76.5% specificity in adults aged 18 years or over, with a
low overall false negative rate of under 2% and a false
positive rate of 13.3% [8,9]. OASIS includes all individ-
uals with asthma identified using this case definition be-
tween April 1, 1996 and March 31, 2010. Since asthma
in early childhood can be misdiagnosed, and up to 50%
of asthma in children remits, [10] we applied an exclu-
sion criterion such that those with an asthma diagnosis
before 5 years of age and did not have a subsequent
asthma health service claim were excluded from this
study. To minimize the potential for misclassifying
prevalent cases as incident cases, we included a ‘look
back’ period, whereby we set a minimum asthma-free
observation period of 5 years prior to incidence date. If
an individual had a claim in the previous 5 years, it was
assumed that they were a prevalent case, not an incident
case. Details regarding the identification of asthmaincident and prevalence cases have been previously pub-
lished [3,8].
Measures of the burden of asthma
The asthma measures were presented as incidence (per
1,000 population) and prevalence (per 100 population)
rates, stratified by sex, rural residence (communities with
less than 10,000 people), and the Ontario Marginalization
Index (ON-Marg) [11]. The ON-Marg is a census and
geographically based index derived to show differences in
marginalization between areas and to understand inequal-
ities in various measures of health and social well-being in
populations or geographical areas. This index includes
four dimensions, including material deprivation (no high
school graduation, lone parent families, government trans-
fers, unemployment, low income, homes needing major
repairs), dependency (seniors, ratio of population ages
0–14 and 65+ to population ages 15–64, labor force par-
ticipation), residential instability (living alone, youth, per-
sons per dwelling, apartments, married, owner-occupied
house, residential mobility in past 5 years) and ethnic con-
centration (recent immigrants and visible minorities). The
index applies to small, relatively stable population between
2,500 and 8,000 living with similar economic and social
conditions. In these analyses we used the deprivation
domain as a proxy measure of socio economic status,
expressed in quintiles, with Q1 being the least and Q5 the
most deprived populations.
Statistical analysis
We applied double exponential smoothing methods [12]
to annual data and projected incidence to the year 2022.
All series were initially inspected for trend and seasonal-
ity (Cyclical Component); in this case the seasonal com-
ponent did not apply. We evaluated each time series
independently and chose the most appropriate model
based on three diagnostic criteria: independent residuals,
stationary time series and the Ljung-Box test. [13]. The
final best model was selected primarily based on the
agreement with assumptions of the models and the
goodness-of-fit criteria. Analyses were conducted using
the forecast package in the statistical program R [14].
The assumptions underlying the population projections
(regarding fertility, immigration and mortality, interpro-
vincial migration and non-permanent residents) are de-
veloped from various data sources: population estimates,
vital statistics and administrative files. These models are
based on several assumptions. 1) The observed trends
during the past 14 years will reflect future trends; 2)
there will be no major changes in the determinants,
treatment of asthma, severity or long term prognosis; 3)
that the risk factors and triggers for asthma do not
change; and 4) once an individual enters the OASIS co-
hort it is assumed that their asthma does not remit. To
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incidence rates and applied these to the medium projected
population estimates for the province of Ontario, adding
the cumulative projected incidence cases to the prevalent
population in 2009. The base population for these projec-
tions was derived from the official post censal estimates
on July 1, 2009, with projections established using the
components method.
Estimates of absolute burden
The projected rates obtained from the time series
models were then applied to the age-specific projected
Ontario population to estimate the absolute asthma bur-
den in 2012 and 2022. The Ontario population estimates
for 2012 and 2022 were obtained from the medium
population projections from Statistics Canada [15]. All
projected numbers were presented to the nearest thou-
sand in order to reduce errors due to rounding.
This study was approved by the Research Ethics Board
at The Hospital for Sick Children Research Institute, and
the Institute for Clinical Evaluative Sciences, in Toronto,
Canada.
Results
Observed data from 1996 to 2009 showed a gradual de-
cline in the newly diagnosed asthma cases in Ontario
(Figure 1), and in each of the age groups (Table 1). The
decreasing incidence trend was forecasted to continue
and estimated to be 4.7 per 1,000 (95%CI: 3.5, 6.3) in
2022. The cumulative prevalence has been gradually in-















































Figure 1 Projected incidence and prevalence rates.continue (Figure 1, Table 1). The prevalence of asthma
was forecasted to be 12.5% (95%CI: 11.3, 14.2) in 2022,




Asthma incidence was consistently higher in urban
populations compared to individuals living in rural
regions (Table 1). However, the relative gap between
urban and rural residence was forecasted to widen
for asthma incidence claims in 2022.
b) Ontario Marginalization Index
In 1996 the most marginalized populations (Q5) had
the highest asthma incidence (10.5 per 1,000 popula-
tion), whereas in 2022 we projected that the least mar-
ginalized group will have the highest incidence of asthma
(4.5 per 1,000 (95%CI: 4.3, 4.7) population), albeit a simi-
lar rate was observed in 1996.
Absolute burden
Applying the forecasted rates to the projected Ontario
population, in 2022 there will be more than 71,000 new
cases of asthma and more than 1.9 million individuals
living with asthma.
Discussion
Our time series forecasting suggests that despite asthma
incidence is decreasing in Ontario, asthma will continue2010 2015 2020
ear
Table 1 Observed and forecasted asthma incidence, 1996 to 2022 in Ontario
Observed Forecasted
1996 2009 2012 2022
Number Rate Number Rate Number Rate (95%CI*) Number Rate (95%CI*) ETS Model
Ontario population 11 082 903 11 838 462 13 532 864
Incidence per 1,000 population
Age groups in years:
5-9 22 101 32.7 18 092 27.9 20 500 27.9 (16.0, 48.9) 23 500 27.9 (8.7, 90.1) M, N, N
10-19 12 606 9.3 8 444 6.0 9 400 5.8 (4.8, 7.2) 9 500 5.8 (4.6, 7.4) A, Ad, N
20-39 20 683 6.1 9 537 2.9 10 000 2.7 (2.2, 3.3) 10 200 2.5 (2.1, 3.0) A, A, N
40-59 15 395 5.8 10 977 3.1 12 200 3.1 (1.9, 4.8) 12 300 3.1 (1.2, 8.2) M, A, N
60+ 13 246 7.7 7 970 3.6 9 800 3.6 (2.4, 5.4) 13 600 3.6 (1.5, 8.6) M, M, N
Setting:
Rural 10 624 8.7 4 568 3.2 NA 2.5 (2.3, 2.6) NA 1.1 (1.0, 1.1) A, A, N
Urban 73 294 7.8 50 429 4.8 NA 4.3 (3.9, 4.8) NA 3.0 (2.4, 3.7) A, A, N
Marginalization quintiles: A, A, N
1 (least marginalized) 15 323 5.7 15 323 4.8 NA 4.6 (4.4, 4.9) NA 4.5 (4.3, 4.7) A, Ad, N
2 17 311 7.4 17 311 4.6 NA 4.1 (3.9, 4.3) NA 3.1 (3.0, 3.3) M, M, N
3 16 834 8.3 16 834 4.4 NA 3.8 (3.5, 4.2) NA 2.3 (1.9, 2.8) A, A, N
4 15 812 9.4 15 812 4.4 NA 3.7 (3.3, 4.1) NA 2.0 (1.5, 2.7) A, A, N
5 (most marginalized) 15 337 10.5 15 337 5.0 NA 4.2 (3.8, 4.7) NA 2.4 (1.9, 3.0) A, A, N
*95%CI = 95% Confidence Intervals.
Note: NA = Not applicable since no projected population data available, ETS = error, trend, seasonality, M = multiplicative, N = none, A = Additive,
Ad = damped additive.
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system in 2022. We projected that about 1 in 8 individ-
uals in Ontario will have asthma by the year 2022, com-
pared to about 1 in 10 in 2009. If we applied our
projected rates to the rest of Canada, we projected that
there will be more than 5.5 million people (95%CI: 5.0
million, 6.2 million) living with asthma, and more than
205,000 new cases (95%CI: 152,000; 277,000) of asthma
in 2022.
In our analysis we applied the same asthma definition
at the population level, thereby using consistent trend
data to make projections into the future. Our findings
on the trends of asthma incidence and prevalence are
consistent with those reported by others; the asthma
prevalence in Ontario in 2009 (9.6%) was similar to that
estimated in the US in 2009 (8.3%) [4]. Most recent
studies have suggested evidence of a stabilization or de-
clining asthma prevalence since the late 1990s, [16-20]
however, the explanation for the apparent stabilization
of asthma prevalence remains elusive. Both our observed
and projected asthma incidence suggested a declining
trend in Ontario, which may have contributed to the sta-
bilizing prevalence of asthma. This stabilizing prevalence
of asthma in Ontario in turn may have contributed to
the decrease in asthma health services use in recent
years [6,21].Previous studies suggested that lower socioeconomic
status was related to a higher asthma burden [22,23]. It
may be associated with the poor affordability and acces-
sibility of asthma medications which may still be major
barriers to long-term asthma control especially in pri-
vately insured health care systems. We observed health
inequalities narrowing for asthma incidence and preva-
lence, which have large public health implications. While
individual level data pertaining to socioeconomic pos-
ition and deprivation are preferable, the ON-Marg index
has been demonstrated to be stable across time periods
and geographic areas, and has been found to be associ-
ated with other health outcomes [11,24-28]. Further-
more, this multi-dimensional marginalization index may
be a more sensitive proxy of SES, as it encompasses sev-
eral elements of social well-being, not just income or
education. While there is universal primary health care
in Canada, there is a lack of universal insurance for
medications in Ontario. Therefore, improving both the
affordability and accessibility of asthma medications
through public health policies and interventions is an
important priority to improve asthma outcomes.
Although it is not possible to make causal inferences,
our observations in asthma trends between 1996 and
2009 may reflect population level changes in risk factors
and the environment which may have largely impacted
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marginalized populations. For instance, smoking bans
began in 1994 in Ontario with a province-wide smoking
ban implemented in all pubic and work places in 2006
[29]. These policies appear to have had a direct impact
on the rates of smoking; such that between 1995 and
2005 the prevalence of smoking in Ontario decreased
by 18.9% [30,31]. Previous studies have shown that am-
bient levels of NO2, SO2, PM2.5 were associated with in-
creased asthma visits in Toronto, Ontario, and that the
burden of poor air quality disproportionately affected
the poor [32]. Clean air initiatives have resulted in sub-
stantial improvements of air quality in the province, [33]
suggesting NO2, CO, SO2, have decreased by as much as
64% since 2000 [33]. Although, these are ecological ob-
servations, they provide a contextual landscape.
Some studies in the US have reported no difference
in asthma prevalence between rural and urban areas,
with others reporting a higher prevalence in rural areas
[34-37]. However, in Canada, a higher prevalence of
asthma in urban areas has been reported in the literature
[38,39]. We have also previously documented that the
lifetime risk of developing asthma is higher in urban
populations compared to rural populations [40]. It has
been suggested that rural populations could experience
lower asthma prevalence for several reasons. For ex-
ample, there is less outdoor air pollution in rural com-
munities. Secondly, growing up on farms or around
animals can expose people to microbes that could lead
to altered immune system development, and potentially
lessen the chance of developing allergies or asthma.
However, it is possible that reduced access to healthcare
could lead to reduced case detection in rural communi-
ties and therefore a lower reported/estimated prevalence
[41,42]. On the other hand, the higher prevalence of
asthma in urban populations could be related to other
risk factors such as poverty, air pollution, immigrant sta-
tus, and minority status [22,23]. However, our study did
not have risk factor data to measure these potential as-
sociations. Future studies could examine these determi-
nants in greater detail.
One limitation of using health administrative data-
bases to identify individuals with asthma is that it was
based on the use of physician-diagnosed asthma only,
which can be subject to misclassification bias. However,
others have found that while differences in absolute
values exist between health administrative data and sur-
vey data, health administrative data are consistent over
time, and are thus reliable for studying asthma trends
[3,43]. Another limitation is that because the study
population was identified from health services use ad-
ministrative data, those individuals with asthma that did
not encounter the health system for either diagnosing/
treating asthma would potentially be missed and weretherefore unidentifiable. In Canada, a recent study
conducted by Aaron et al [44] found that about one-
third of individuals with physician-diagnosed asthma
actually did not have asthma when objectively assessed.
Their finding suggests that, in developed countries
such as Canada, asthma is overdiagnosed rather than
underdiagnosed.
Because asthma incidence was identified and projected
from 14 years of observed data, a limitation is that it is
possible for physician and patient behavior to have
changed and for the diagnosis of asthma to have im-
proved, meaning that the validation done previously
would no longer be appropriate. There is also some un-
certainty to the projections, demonstrated by confidence
intervals, as we were limited to 14 years of observed data
and projected 13 years into the future. In addition, our
projections do not make assumptions regarding poten-
tial changes in asthma triggers, diagnosis or treatments
in the future, and how incidence, prevalence and health
services utilization may change in response to these fac-
tors. Finally, while the OASIS cohort is a comprehensive
registry of asthma cases in Ontario, the nature of the co-
hort is such that once an individual is classified as hav-
ing asthma, they remain in the prevalence pool until
they die, or move from Ontario. Since we are not certain
whether asthma can remit, we compared rates after ap-
plying a 20% remission rate; this figure is based on a re-
cent study which showed 20% of the OASIS cohort did
not have an asthma related visit following their index
date for up to 15 years after their index date [45]. Based
on these figures, we would project 1.6 million (compared
with 1.9 million) people in the province of Ontario
would be living with asthma in 2022. Despite the uncer-
tainties around the projected estimates, our results have
the potential to guide decision makers about health
service needs related to asthma, provided they are
interpreted with caution and within the context of
current data. As more data become available, these pro-
jections should be updated and re-calibrated.
Conclusion
This study applied time series methods to population-
based data and demonstrated its ability to measure and
project trends in asthma incidence and prevalence.
These projections may help examine practice varia-
tions, monitor gaps in care across various areas and
over time. Health care planners and decision-makers
may use these projected estimates to identify problems,
design and evaluate solutions today and for the future.
While we projected a decreasing asthma incidence in
the next decade, the burden of asthma remains substan-
tial. Our findings support ongoing efforts to implement
effective asthma management and patient education
interventions.
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